
A Monday-morning next-session forecast for 12 major technology shares, using fresh catalysts, analyst revisions, sector breadth, investor positioning and relative-strength failures to isolate the strongest calls before the U.S. open.

An August 7 Market Momentum scan of Airbnb, healthcare and industrials after a surprise payroll decline lowered rate-hike fears, separating a live earnings breakout from broader sector rotation.

A pre-payroll outlook for 12 major technology shares, using fresh news, analyst revisions, premarket leadership and public investor sentiment to separate the strongest chip setups from crowded or unstable trades.

An August 6 Market Momentum scan of Moderna, Keurig Dr Pepper and gold, separating two event-driven stock moves from a broader macro momentum signal.

Daily technology and AI market report for August 6, 2026, covering Nvidia’s breakout, AMD’s post-earnings reset, Alphabet’s AI leadership shake-up, and short-term setups across 12 major tickers.

An August 5 Market Momentum scan of Eli Lilly, Disney and Booking Holdings, ranking a guidance-driven healthcare surge against two consumer earnings moves.

AMD beat estimates and raised its outlook, but the initial after-hours selloff showed how high expectations have become after a 6.6% semiconductor rally.

An August 4 Market Momentum scan of Caterpillar, BP and Pfizer, separating a broad earnings breakout from slower energy and healthcare confirmation.

Daily technology and AI stock report for August 4, 2026, covering Amazon's $3 trillion milestone, Microsoft's AI rally, AMD earnings risk and short-term setups across 12 major tickers.

A live August 3 Market Momentum scan comparing Boeing’s upgrade-backed rally, airline stocks’ oil-price relief and Bristol Myers Squibb’s merger premium.

A short-term trading report for major technology and AI stocks after divergent megacap earnings, a hawkish Fed hold, and renewed semiconductor volatility.

A weekend Market Momentum scan of Guardant Health, Viking Holdings and Navios Maritime Partners after the July 31, 2026 U.S. session, with catalysts, risks and invalidation tests.